(Q43651598)

25 November 2017

title

A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis (English)

1 reference

25 November 2017

1 reference

1 reference

Koutinas AF

1

1 reference

25 November 2017

Saridomichelakis MN

2

1 reference

25 November 2017

Mylonakis ME

3

1 reference

25 November 2017

Leontides L

4

1 reference

25 November 2017

Polizopoulou Z

5

1 reference

25 November 2017

Billinis C

6

1 reference

25 November 2017

Argyriadis D

7

1 reference

25 November 2017

Diakou N

8

1 reference

25 November 2017

Papadopoulos O

9

1 reference

25 November 2017

publication date

1 July 2001

1 reference

25 November 2017

published in

Veterinary Parasitology

1 reference

25 November 2017

volume

98

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

247-261

1 reference

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Skin lesions in canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Serological diagnosis and treatment of canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Use of allopurinol for maintenance of remission in dogs with leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Clinical considerations on canine visceral leishmaniasis in Greece: a retrospective study of 158 cases (1989-1996)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Allopurinol in the treatment of canine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Comparison between an enzyme-linked immunosorbent assay using a detergent-soluble Leishmania infantum antigen and indirect immunofluorescence for the diagnosis of canine leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Rapid identification of causative species in patients with Old World leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Urinary protein/creatinine ratio in the evaluation of renal failure in canine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Drug-induced nephropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Renal involvement in canine leishmaniasis. A light-microscopic, immunohistochemical and electron-microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Diagnosis of canine leishmaniasis by a polymerase chain reaction technique

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Canine leishmaniasis. A review based on 95 cases in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Development of a slide ELISA for canine leishmaniasis and comparison with four serological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

Epidemiological patterns of canine leishmaniasis [correction of leishmaniosis] in Western Liguria (Italy).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4017%2801%2900399-5

7 January 2021

10.1016/S0304-4017(01)00399-5

Identifiers

DOI

1 reference

25 November 2017

1 reference